Bone Therapeutics reports positive efficacy data for the ALLOB® Phase IIA spinal fusion trial Read more about Bone Therapeutics reports positive efficacy data for the ALLOB® Phase IIA spinal fusion trial
Transparency notification received from Theodorus II SA Read more about Transparency notification received from Theodorus II SA
Enrico Bastianelli to stand down as CEO of Bone Therapeutics Read more about Enrico Bastianelli to stand down as CEO of Bone Therapeutics
Bone Therapeutics Notice of Q3 2016 Results - Results to be announced on 8 November 2016 Read more about Bone Therapeutics Notice of Q3 2016 Results - Results to be announced on 8 November 2016
Bone Therapeutics Business Update for Third Quarter 2016 Read more about Bone Therapeutics Business Update for Third Quarter 2016
Bone Therapeutics announces its financial calendar for 2017 Read more about Bone Therapeutics announces its financial calendar for 2017
Bone Therapeutics Granted EUR 2.3 Million in Non-Dilutive Funding by the Walloon Region Read more about Bone Therapeutics Granted EUR 2.3 Million in Non-Dilutive Funding by the Walloon Region
Bone Therapeutics Provides Business Update for Q4 2016 Read more about Bone Therapeutics Provides Business Update for Q4 2016
Bone Therapeutics réaffirme son éligibilité au PEA-PME pour 2017 Read more about Bone Therapeutics réaffirme son éligibilité au PEA-PME pour 2017
Bone Therapeutics Notice of Full Year 2016 Results Read more about Bone Therapeutics Notice of Full Year 2016 Results
